IFNG and Mendelian susceptibility to mycobacterial diseases: Additionally, IL-23 signaling in humans promotes type 1 immunity, as IL23R−/− patients have reduced IFN-γ expression, clinically manifesting as Mendelian susceptibility to mycobacterial disease (MSMD)28–30.